Nonfamilial Unilateral Linear Eccrine Syringofibroadenoma of the Plantar Surface: A Diagnostic Consideration in Acral Eccrine Proliferations.

Am J DermatopatholMay 27, 2026 (epub)
Case ReportDermatology

Jing Xu, Lianjun Chen, Huyan Chen et al.

✦ AI-curated · Sources linked

Case in brief

A middle-aged woman presented with a long-standing unilateral linear lesion on the plantar surface of her foot. Histopathological analysis revealed anastomosing epithelial cords and eccrine duct-like structures within a fibrovascular stroma, confirming the diagnosis of eccrine syringofibroadenoma (ESFA). The lesion was successfully identified and differentiated from other similar conditions.

What made this case unusual

The case highlights the nonfamilial unilateral linear subtype of ESFA, which is exceedingly rare and can complicate diagnosis, especially in acral locations.

Diagnostic / clinical pearl

Clinicians should be aware of the distinctive histopathological features of eccrine syringofibroadenoma to differentiate it from other eccrine proliferations.

Why it matters

This case underscores the importance of recognizing rare benign neoplasms like ESFA in dermatopathology, particularly in challenging acral presentations.

Source

Published in Am J Dermatopathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.